CN118055925A - 化合物或其药学上允许的盐的制造方法 - Google Patents

化合物或其药学上允许的盐的制造方法 Download PDF

Info

Publication number
CN118055925A
CN118055925A CN202280067043.4A CN202280067043A CN118055925A CN 118055925 A CN118055925 A CN 118055925A CN 202280067043 A CN202280067043 A CN 202280067043A CN 118055925 A CN118055925 A CN 118055925A
Authority
CN
China
Prior art keywords
compound
formula
crystal
following
synthesis route
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280067043.4A
Other languages
English (en)
Chinese (zh)
Inventor
南川亮
松谷乡
真方祐哉
川西真司
川平瑞季
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of CN118055925A publication Critical patent/CN118055925A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN202280067043.4A 2021-10-05 2022-10-04 化合物或其药学上允许的盐的制造方法 Pending CN118055925A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021164171 2021-10-05
JP2021-164171 2021-10-05
PCT/JP2022/037098 WO2023058645A1 (ja) 2021-10-05 2022-10-04 化合物又はその薬学的に許容される塩の製造方法

Publications (1)

Publication Number Publication Date
CN118055925A true CN118055925A (zh) 2024-05-17

Family

ID=85803498

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280067043.4A Pending CN118055925A (zh) 2021-10-05 2022-10-04 化合物或其药学上允许的盐的制造方法

Country Status (11)

Country Link
US (1) US20240262805A1 (https=)
EP (1) EP4414362A4 (https=)
JP (1) JPWO2023058645A1 (https=)
KR (1) KR20240073943A (https=)
CN (1) CN118055925A (https=)
AU (1) AU2022361862A1 (https=)
CA (1) CA3234498A1 (https=)
IL (1) IL311879A (https=)
MX (1) MX2024004049A (https=)
TW (1) TW202330490A (https=)
WO (1) WO2023058645A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116947658B (zh) * 2023-07-28 2025-10-28 南通华祥医药科技有限公司 一种1-氨基-2-甲基-2-丙醇的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3269772B1 (en) * 2015-03-10 2020-11-11 Unimatec Co., Ltd. Fluorine-containing boric acid/pvb composite
ES2856125T3 (es) 2016-02-05 2021-09-27 Ea Pharma Co Ltd Derivado de sulfonamida y composición farmacéutica que contiene la misma
TW201731824A (zh) * 2016-02-05 2017-09-16 Ea Pharma Co Ltd α4β7整合蛋白抑制劑
JP2019031449A (ja) * 2017-08-04 2019-02-28 Eaファーマ株式会社 スルホンアミド誘導体及びそれを含有する医薬組成物

Also Published As

Publication number Publication date
EP4414362A4 (en) 2025-09-03
IL311879A (en) 2024-06-01
WO2023058645A1 (ja) 2023-04-13
CA3234498A1 (en) 2023-04-13
AU2022361862A1 (en) 2024-04-18
JPWO2023058645A1 (https=) 2023-04-13
KR20240073943A (ko) 2024-05-27
US20240262805A1 (en) 2024-08-08
MX2024004049A (es) 2024-04-25
TW202330490A (zh) 2023-08-01
EP4414362A1 (en) 2024-08-14

Similar Documents

Publication Publication Date Title
CN116897149A (zh) 一种连接基药物偶联物的制备方法及其中间体
TW202210486A (zh) 一種製備glp—1受體激動劑的方法
CN107810189B (zh) 用于制备氮芥衍生物的方法
CN108264537A (zh) 二甲磺酸赖右苯丙胺类似物、制备方法、中间体和应用
US20240262805A1 (en) Method for producing compound or pharmaceutically acceptable salt thereof
CN108148044B (zh) 酰胺类化合物及该化合物制备富马酸沃诺拉赞的方法
CN113024637A (zh) 一种以水溶性炔酰胺作为缩合剂制备卡非佐米的方法
JP2659990B2 (ja) 結晶性キナプリルおよびその製法
HK40111936A (en) Method for producing compound or pharmaceutically acceptable salt thereof
HK40106397A (zh) 化合物或其药学上允许的盐的制造方法
JP4190879B2 (ja) テアニンを製造するための新規な中間体
JPH06104656B2 (ja) スルホニウム化合物およびその製造方法
JPH078855B2 (ja) スルホニウム化合物
JPH08119916A (ja) N−保護グルタミン酸γ−誘導体の選択的製造法
MXPA03000607A (es) Procedimiento quimico.
CN101111498B (zh) 头孢卡品酯的甲磺酸盐
JP2880744B2 (ja) α―L―アスパルチル―L―フェニルアラニンエステルの製造法
JPH0363560B2 (https=)
CN120098068A (zh) 一种醋酸地非法林的制备方法
JPS6110568A (ja) 3‐ヒドロキシ‐4‐オキソ‐3,4‐ジヒドロ‐1,2,3‐ベンゾトリアジンとアミノ化合物の塩
JP3266603B2 (ja) 3−(7−アミジノ−2−ナフチル)−2−フェニルプロピオン酸誘導体の製造方法
CA2720312A1 (en) Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
CN120965808A (zh) 一种半固相合成多环化合物的方法和中间体
JP3266603B6 (ja) 3−(7−アミジノ−2−ナフチル)−2−フェニルプロピオン酸誘導体の製造方法
JP2002265481A (ja) 高分子担持光学活性ホスフィン化合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40106397

Country of ref document: HK